Zika Virus Clinical Trial Says Vaccine Safe Immune Response

Dec 5, 2017, 14:24 by Michael Croft

MiamiHerald | A Zika vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases has cleared the first phase of clinical trials. Findings were published in The Lancet, a medical journal.

December 05, 2017 | A Zika vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases has cleared the first phase of clinical trials. Findings were published in The Lancet, a medical journal. MiamiHerald